Correlation Between Bristol Myers and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Novartis AG ADR, you can compare the effects of market volatilities on Bristol Myers and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Novartis.

Diversification Opportunities for Bristol Myers and Novartis

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Bristol and Novartis is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Bristol-Myers Squibb and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Bristol Myers i.e., Bristol Myers and Novartis go up and down completely randomly.

Pair Corralation between Bristol Myers and Novartis

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Novartis. In addition to that, Bristol Myers is 1.06 times more volatile than Novartis AG ADR. It trades about -0.04 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.03 per unit of volatility. If you would invest  8,169  in Novartis AG ADR on December 30, 2023 and sell it today you would earn a total of  1,504  from holding Novartis AG ADR or generate 18.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bristol-Myers Squibb  vs.  Novartis AG ADR

 Performance 
       Timeline  
Bristol-Myers Squibb 

Risk-Adjusted Performance

4 of 100

 
Low
 
High
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Novartis is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Bristol Myers and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Novartis

The main advantage of trading using opposite Bristol Myers and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Bristol Myers Squibb and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum